Pays: Australie
Langue: anglais
Source: Department of Health (Therapeutic Goods Administration)
Clopidogrel hydrogen sulfate
Sandoz Pty Ltd
Medicine Registered
Clopidogrel Sandoz ® 1 CLOPIDOGREL SANDOZ ® _ _ CLOPIDOGREL HYDROGEN SULFATE FILM-COATED TABLETS_ _ CONSUMER MEDICINE INFORMATION (CMI) WHAT IS IN THIS LEAFLET This leaflet answers some common questions about Clopidogrel Sandoz. It does not contain all the available information. It does not take the place of talking to your doctor or pharmacist. All medicines have risks and benefits. Your doctor has weighed the risks of you taking this medicine against the benefits they expect it will have for you. IF YOU HAVE ANY CONCERNS ABOUT TAKING THIS MEDICINE, ASK YOUR DOCTOR OR PHARMACIST. KEEP THIS LEAFLET WITH THE MEDICINE. You may need to read it again. WHAT CLOPIDOGREL SANDOZ IS USED FOR This medicine is used to prevent blood clots forming and to reduce the risk of heart attack, stroke or death in patients who have previously suffered a heart attack, stroke or have a condition known as peripheral arterial disease (leg pain when walking or at rest)._ _ This medicine contains the active ingredient clopidogrel. Clopidogrel belongs to a group of medicines called anti-platelet medicines._ _ It works by preventing blood clots to form in hardened blood vessels. This process is called atherothrombosis and can lead to events such as stroke, heart attack or death. ASK YOUR DOCTOR IF YOU HAVE ANY QUESTIONS ABOUT WHY THIS MEDICINE HAS BEEN PRESCRIBED FOR YOU. Your doctor may have prescribed it for another reason. This medicine is available only with a doctor’s prescription. BEFORE YOU TAKE CLOPIDOGREL SANDOZ _WHEN YOU MUST NOT TAKE IT _ DO NOT TAKE THIS MEDICINE IF YOU HAVE AN ALLERGY TO: • clopidogrel, the active ingredient, or to any of the other ingredients listed at the end of this leaflet under ‘Product description’. Some of the symptoms of an allergic reaction may include: • shortness of breath • wheezing or difficulty breathing • swelling of the face, lips, tongue Lire le document complet
_Product Information _ _ _ _Page _1_ _ _Clopidogrel Sandoz 75mg film-coated tablets _ _01/2012 _ _Sandoz Pty Ltd _ _ _ _Version 1 _ PRODUCT INFORMATION CLOPIDOGREL SANDOZ 75MG FILM-COATED TABLETS NAME OF THE MEDICINE Generic name: Clopidogrel hydrogen sulfate Chemical name: Methyl (+)-(S)-α-(2-chlorophenyl)-6,7-dihydrothieno[3,2-c] pyridine-5(4H)-acetate sulfate (1:1) CAS: 120202-66-6 (Clopidogrel hydrogen sulfate) 113 665-84-2 (Clopidogrel base) Empirical formula: C 16 H 16 ClNO 2 S.H 2 SO 4 MW: 419.9 DESCRIPTION Clopidogrel hydrogen sulfate is a white to off-white powder. It is practically insoluble in water at neutral pH but freely soluble at pH 1. It is freely soluble in methanol, sparingly soluble in methylene chloride and is practically insoluble in ethyl ether. It has a specific optical rotation of about + 56°. Each tablet contains mannitol, microcrystalline cellulose, hydroxypropylcellulose, hydrogenated vegetable oil, Opadry Pink 03B54942 and Opacode S-1-27794 Black. PHARMACOLOGY Pharmacodynamics Clopidogrel is a specific and potent inhibitor of platelet aggregation. Platelets have an established role in the pathophysiology of atherosclerotic disease and thrombotic events. Long term use of anti-platelet drugs has shown consistent benefit in the prevention of ischaemic stroke, myocardial infarction and vascular death in patients at increased risk of such outcomes, including those with established atherosclerosis or a history of atherothrombosis. Clopidogrel selectively inhibits the binding of adenosine diphosphate (ADP) to its platelet receptor, and the subsequent ADP-mediated activation of the GPIIb/IIIa complex, thereby inhibiting platelet aggregation. Biotransformation of clopidogrel is necessary to produce inhibition of platelet aggregation. The active metabolite, a thiol _Product Information _ _ _ _Page _2_ _ _Clopidogrel Sandoz Lire le document complet